Vortioxetine–Lurasidone Augmentation for Compulsive Scratching Behavior in Prader–Willi Syndrome: A Case Report
Neuropsychopharmacology Reports · 2026-06 · 46 (2)
DOI: 10.1002/npr2.70145 ↗Kurz gefasst
Fallbericht in der Zeitschrift Neuropsychopharmacology Reports, online erschienen am 17.06.2026. Verfasst von Yasuhide Nagoshi. Beteiligte Einrichtung: Department of Psychiatry, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto, Japan. Hauptthemen laut MEDLINE: Lurasidone Hydrochloride, Prader-Willi Syndrome, Vortioxetine, Compulsive Behavior. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Prader–Willi syndrome (PWS) is a rare genetic disorder frequently associated with repetitive and self‐injurious behaviors such as skin picking. Effective pharmacological treatments for compulsive scratching behavior in PWS remain limited. Case Presentation We report the case of a 19‐year‐old woman with PWS presenting with severe, persistent scratching behavior resulting in repeated excoriations. Escitalopram produced partial improvement but was discontinued because of sedation. Treatment was switched to vortioxetine, which reduced the frequency of scratching but did not achieve remission. Subsequent augmentation with lurasidone resulted in marked improvement, with episodes decreasing from daily occurrences to once every 1–3 months and lasting only a few minutes. The patient remained stable for 2 years without recurrence of severe symptoms.
Conclusion
This case suggests that vortioxetine and lurasidone may represent a potential pharmacological option for severe scratching behavior in PWS. Further studies are needed to clarify the therapeutic role of this combination approach.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Psychiatry, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto, Japan.
ORCID-Profile: Yasuhide Nagoshi
Zitieren
APA
Nagoshi, Y. (2026). Vortioxetine–Lurasidone Augmentation for Compulsive Scratching Behavior in Prader–Willi Syndrome: A Case Report. Neuropsychopharmacology Reports, 46(2). https://doi.org/10.1002/npr2.70145
Vancouver
Nagoshi Y. Vortioxetine–Lurasidone Augmentation for Compulsive Scratching Behavior in Prader–Willi Syndrome: A Case Report. Neuropsychopharmacology Reports. 2026;46(2). doi:10.1002/npr2.70145
BibTeX
@article{Nagoshi2026,
author = {Nagoshi, Yasuhide},
title = {Vortioxetine–Lurasidone Augmentation for Compulsive Scratching Behavior in Prader–Willi Syndrome: A Case Report},
journal = {Neuropsychopharmacology Reports},
year = {2026},
volume = {46},
number = {2},
doi = {10.1002/npr2.70145}
}
EUVIMED